Caribou Biosciences, Inc. (CRBU) Misses Q4 EPS by 2c

Caribou Biosciences, Inc. (NASDAQ: CRBU) reported Q4 EPS of ($0.39), $0.02 worse than the analyst estimate of ($0.37). Revenue for the quarter came in at $3.56 million versus the consensus estimate of $3.95 million.

For earnings history and earnings-related data on Caribou Biosciences, Inc. (CRBU) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Alphabet slides over 6% as AI brain drain and SpaceX slump converge
• C.H. Robinson acquires DeSpir Logistics for $75 million